The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman of Moderna and the CEO of Flagship Pioneering, a venture capital firm that helped launch Moderna. He joins Judy Woodruff to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
- Category
- U.S. & Canada
- Tags
- Moderna, Moderna interview, Moderna vaccine update
Sign in or sign up to post comments.
Be the first to comment